These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 21116684)

  • 41. Differential tapasin dependence of MHC class I molecules correlates with conformational changes upon peptide dissociation: a molecular dynamics simulation study.
    Sieker F; Straatsma TP; Springer S; Zacharias M
    Mol Immunol; 2008 Aug; 45(14):3714-22. PubMed ID: 18639935
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sequence-structure-function relationships in class I MHC: A local frustration perspective.
    Serçinoğlu O; Ozbek P
    PLoS One; 2020; 15(5):e0232849. PubMed ID: 32421728
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enhancement of tumour-specific immune responses in vivo by 'MHC loading-enhancer' (MLE).
    Dickhaut K; Hoepner S; Eckhard J; Wiesmueller KH; Schindler L; Jung G; Falk K; Roetzschke O
    PLoS One; 2009 Sep; 4(9):e6811. PubMed ID: 19738910
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Based on HLA-DR beta1* allele binding specificities, striking differences in distance and TCR Contacting Residue Orientation can be observed in modified protection-inducing malarial synthetic peptides.
    Patarroyo ME; Cifuentes G; Salazar LM; Espejo F; Alba MP; Bermúdez A
    Curr Med Chem; 2005; 12(24):2849-65. PubMed ID: 16305475
    [TBL] [Abstract][Full Text] [Related]  

  • 45. DR alpha: E beta heterodimers in DRA transgenic mice hinder expression of E alpha: E beta molecules and are more efficient in antigen presentation.
    Trembleau S; Giacomini P; Guéry JC; Setini A; Hammer J; Sette A; Appella E; Adorini L
    Int Immunol; 1995 Dec; 7(12):1927-38. PubMed ID: 8746562
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Computational characterization of residue couplings and micropolymorphism-induced changes in the dynamics of two differentially disease-associated human MHC class-I alleles.
    Serçinoğlu O; Ozbek P
    J Biomol Struct Dyn; 2018 Feb; 36(3):724-740. PubMed ID: 28278760
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rheumatoid arthritis (RA)-associated HLA-DR alleles form less stable complexes with class II-associated invariant chain peptide than non-RA-associated HLA-DR alleles.
    Patil NS; Pashine A; Belmares MP; Liu W; Kaneshiro B; Rabinowitz J; McConnell H; Mellins ED
    J Immunol; 2001 Dec; 167(12):7157-68. PubMed ID: 11739539
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A comparative study of MHC Class-II HLA-DRbeta1*0401-Col II and HLA-DRbeta1*0101-HA complexes: a theoretical point of view.
    Cárdenas C; Villaveces JL; Suárez C; Obregón M; Ortiz M; Patarroyo ME
    J Struct Biol; 2005 Jan; 149(1):38-52. PubMed ID: 15629656
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Distinct conformations of a peptide bound to HLA-DR1 or DRB5*0101 suggested by molecular modelling.
    Jurcevic S; Travers PJ; Hills A; Agrewala JN; Moreno C; Ivanyi J
    Int Immunol; 1996 Nov; 8(11):1807-14. PubMed ID: 8943576
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Peptide motif for the rat MHC class II molecule RT1.Da: similarities to the multiple sclerosis-associated HLA-DRB1*1501 molecule.
    Duyar H; Dengjel J; de Graaf KL; Wiesmüller KH; Stevanović S; Weissert R
    Immunogenetics; 2005 Apr; 57(1-2):69-76. PubMed ID: 15711804
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HLA-DR53 molecules restrict glutamic acid decarboxylase peptide presentation to T cells of a Type I diabetes patient: specification of the trimolecular HLA-peptide/T-cell receptor complex.
    Huck C; Endl J; Walk T; Noessner E; Jung G; Wank R; Schendel DJ
    Diabetologia; 2001 Jan; 44(1):70-80. PubMed ID: 11206414
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Structural prediction of peptides binding to MHC class I molecules.
    Bui HH; Schiewe AJ; von Grafenstein H; Haworth IS
    Proteins; 2006 Apr; 63(1):43-52. PubMed ID: 16447245
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mediation by HLA-DM of dissociation of peptides from HLA-DR.
    Sloan VS; Cameron P; Porter G; Gammon M; Amaya M; Mellins E; Zaller DM
    Nature; 1995 Jun; 375(6534):802-6. PubMed ID: 7596415
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Surface-expressed invariant chain (CD74) is required for internalization of human leucocyte antigen-DR molecules to early endosomal compartments.
    Moldenhauer G; Henne C; Karhausen J; Möller P
    Immunology; 1999 Mar; 96(3):473-84. PubMed ID: 10233730
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Analysis of peptide-binding motifs for two disease associated HLA-DR13 alleles using an M13 phage display library.
    Davenport MP; Quinn CL; Valsasnini P; Sinigaglia F; Hill AV; Bell JI
    Immunology; 1996 Aug; 88(4):482-6. PubMed ID: 8881746
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Revisiting the structural basis and energetic landscape of susceptibility difference between HLA isotypes to allergic rhinitis.
    Mao XL; Zhu F; Pan ZH; Wu GM; Zhu HY
    Comput Biol Chem; 2016 Oct; 64():210-216. PubMed ID: 27433817
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of HLA-DR1 beta chain residues critical for binding staphylococcal enterotoxins A and E.
    Karp DR; Long EO
    J Exp Med; 1992 Feb; 175(2):415-24. PubMed ID: 1370684
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of the HLA-DM/HLA-DR interface.
    Davies MN; Lamikanra A; Sansom CE; Flower DR; Moss DS; Travers PJ
    Mol Immunol; 2008 Feb; 45(4):1063-70. PubMed ID: 17870168
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Coupling between side chain interactions and binding pocket flexibility in HLA-B*44:02 molecules investigated by molecular dynamics simulations.
    Ostermeir K; Springer S; Zacharias M
    Mol Immunol; 2015 Feb; 63(2):312-9. PubMed ID: 25146482
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Critical contribution of beta chain residue 57 in peptide binding ability of both HLA-DR and -DQ molecules.
    Nepom BS; Nepom GT; Coleman M; Kwok WW
    Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7202-6. PubMed ID: 8692969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.